Propafenone (brand name Rythmol SR or Rytmonorm) is a class Ic
anti-arrhythmic drug that treats illnesses related to rapid heart beats such
as atrial and ventricular arrhythmias. On November 7, 2008, the FDA posted
a press release from ETHEX Corporation announcing the recall of its
generic/non-branded propafenone tablets in the following lots:
Lots: 73761, 78184, 79373, 81240, 81241, 81242, 83470, 84357, 90525, and
90526 with expiration dates ranging from 3/2009 to 3/2011
These lots were recalled as a precaution, as they may contain oversized
tablets, which could result in patients receiving up to twice the
recommended dosage. These patients could experience some serious side
effects, and even risk death. Propafenone HCl overdose side effects might
include arrhythmias (irregular heartbeats) and low blood pressure.
ETHEX Corporation sent its recall notifications to wholesalers and retailers
that received inventory of the Propafenone HCl lots with the possible
oversized tablets. The recall notices give instructions for retailers and
pharmacies to contact consumers given this medication in order that they may
either get replacement of the product or a refund.
Consumers who experience any adverse reactions to Propafenone HCl listed in
the lot numbers above should contact their healthcare providers immediately.
If you or a family member has taken Propafenone HCl tablets and experienced
adverse side effects or died as a result, please fill out our Case Review
Form to the right on this page for a free consultation.
Dangerous Drugs
News Articles
Pfizer Starts Media Ad Blitz to Address Smoking Drug Concerns
May 28 (Bloomberg) – Pfizer Inc.
(read more..)
North Carolina Case Claims Financial Calamity From Bayer Drug
5/2/08 - Triangle Business Journal
(read more..)
Panel May Issue Subpoenas Related to FDA Approval
on Antibiotic Drug Ketek
1/28/08 - FDA
(read more..)
Second Safety Warning on Fentanyl Skin Patch
12/21/07 - FDA
(read more..)
F.D.A. Investigates Quit-Smoking Drug
11/20/07 - Associated Press
(read
more..)
Merck to Pay $4.85 Billion To Settle Most Vioxx Cases
11/09/07 - AngelReyesBlog.com
(read
more..)
Cephalon Drug Is Tied to Several Deaths
9/14/07 - The Wall Street Journal
(read
more..)
$5.5 Million Award in First Federal Fentanyl (Duragesic) Pain Patch Trial
6/19/07 - Press Release
(read
more...)